Sulfadiazine
Sulfadiazine is a prescription antibiotic tablet used to treat certain bacterial infections. It contains 500 mg of sulfadiazine per tablet and is taken orally. Manufactured by Chartwell RX, LLC, it belongs to the sulfonamide class of antibacterials. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Sulfadiazine is a prescription antibiotic tablet used to treat certain bacterial infections. It contains 500 mg of sulfadiazine per tablet and is taken orally. Manufactured by Chartwell RX, LLC, it belongs to the sulfonamide class of antibacterials. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Sulfadiazine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Sulfadiazine — ANDA 017381 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017381"
}
]
|
| identifier | ANDA017381 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"fda",
"health-care"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Sulfadiazine |
